Hsp27 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Hsp27 (Heat Shock Protein 27, encoded by HSPB1) is a small heat shock protein with potent neuroprotective properties. It plays critical roles in protein quality control, cytoskeletal stabilization, and anti-apoptotic signaling in neurons. [1]
| Protein Summary | |
|---|---|
| Name | Hsp27 (HSPB1) |
| Gene | HSPB1 |
| UniProt ID | P04792 |
| Molecular Weight | ~27 kDa |
| Structure | Alpha-crystallin domain |
| Localization | Cytoplasm, nucleus |
| Family | Small Hsp family |
Hsp27 is a 205-amino acid protein with:
The protein forms large oligomers (12-24 subunits) that can dissociate into smaller active forms.
Hsp27 is downregulated in ALS spinal cord and motor cortex. Protective effects include:
HSPB1 mutations (R127W, S135F) cause CMT2F:
Hsp27 levels correlate with disease progression:
Hsp27 protects against:
| Approach | Status | Description |
|---|---|---|
| Small molecule inducers | Preclinical | Arimoclomol, gemfibrozil upregulate Hsp27 |
| Gene therapy | Preclinical | AAV-HSPB1 delivery in models |
| Protein delivery | Research | Recombinant Hsp27 administration |
The study of Hsp27 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Hsp27 (Heat Shock Protein 27, encoded by HSPB1) is a small heat shock protein (sHsp) that functions as a molecular chaperone with unique ATP-independent mechanism of action[2]. Unlike larger Hsp70/Hsp90 chaperones, Hsp27 forms large oligomers (12-32 subunits) that serve as a holding facility for misfolded proteins[1:1].
Hsp27 contains an N-terminal α-crystallin domain and a C-terminal extension that mediates its dynamic oligomerization[3]. The oligomeric state is regulated by phosphorylation at three serine residues (Ser15, Ser78, Ser82) by various kinases including MAPKAPK-2/3 and PKC[4].
Hsp27 directly inhibits caspase activation through multiple mechanisms:
In neurons, Hsp27 protects the actin cytoskeleton from oxidative damage and maintains microtubule stability - critical for axonal transport[^6].
In AD, Hsp27 is upregulated in neurons surrounding amyloid plaques, suggesting a protective response against amyloid-β toxicity[^7]. Hsp27 can:
Hsp27 protects dopaminergic neurons against:
Polymorphisms in the HSPB1 gene have been associated with PD susceptibility in some populations.
Hsp27 represents a promising therapeutic target:
Ackerley S, et al. "HSPB1 and neuroprotection in ALS." Brain. Brain. 2006. ↩︎ ↩︎
Benndorf K, et al. "HSPB1 (Hsp27) in axonal protection and ALS." Nat Genet. Nat Genet. 2001. ↩︎
David S, et al. "HSPB1 mutations causing peripheral neuropathy." Brain. Brain. 2018. ↩︎
Boncoraglio A, et al. "HSPB family in protein aggregation." Biochim Biophys Acta. Biochim Biophys Acta. 2012. ↩︎
C: Björkdahl, C. et al.: Zourlidou, A. et al. Hsp27 and Parkinson's disease. Neurology. 2004. ↩︎